General Catalyst Group Management
Latest statistics and disclosures from General Catalyst Group Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are AVBP, Parabilis Medicines, CART, MAZE, Odyssey Therapeutics, and represent 93.08% of General Catalyst Group Management's stock portfolio.
- Added to shares of these 7 stocks: Parabilis Medicines (+$44M), Odyssey Therapeutics (+$15M), DASH, CVNA, META, CPNG, AMZN.
- Started 4 new stock positions in Odyssey Therapeutics, CVNA, DASH, Parabilis Medicines.
- Reduced shares in these 3 stocks: IOT (-$63M), GTLB (-$20M), GUTS.
- Sold out of its positions in GTLB, IOT.
- General Catalyst Group Management was a net seller of stock by $-22M.
- General Catalyst Group Management has $189M in assets under management (AUM), dropping by 2.70%.
- Central Index Key (CIK): 0001637946
Tip: Access up to 7 years of quarterly data
Positions held by General Catalyst Group Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for General Catalyst Group Management
General Catalyst Group Management holds 14 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Arrivent Biopharma (AVBP) | 27.5 | $52M | 1.5M | 34.74 |
|
|
| Parabilis Medicines | 23.2 | $44M | NEW | 1.6M | 27.37 |
|
| Maplebear (CART) | 17.9 | $34M | 711k | 47.35 |
|
|
| Maze Therapeatics (MAZE) | 16.4 | $31M | 1.0M | 29.84 |
|
|
| Odyssey Therapeutics Common Stock | 8.0 | $15M | NEW | 810k | 18.71 |
|
| Eikon Therapeutics (EIKN) | 2.1 | $4.0M | 305k | 13.05 |
|
|
| Fractyl Health (GUTS) | 2.1 | $3.9M | 4.9M | 0.79 |
|
|
| Ethos Technologies Cl A (LIFE) | 0.7 | $1.3M | 74k | 18.14 |
|
|
| Coupang Cl A (CPNG) | 0.5 | $950k | +49% | 55k | 17.37 |
|
| Amazon (AMZN) | 0.5 | $925k | +50% | 3.9k | 238.34 |
|
| Meta Platforms Cl A (META) | 0.4 | $744k | +100% | 1.3k | 563.29 |
|
| Doordash Cl A (DASH) | 0.3 | $526k | NEW | 2.9k | 184.53 |
|
| Carvana Cl A (CVNA) | 0.2 | $426k | NEW | 6.5k | 65.82 |
|
| Figma Class A Com Stk (FIG) | 0.1 | $269k | 15k | 18.09 |
|
Past Filings by General Catalyst Group Management
SEC 13F filings are viewable for General Catalyst Group Management going back to 2017
- General Catalyst Group Management 2026 Q2 filed Aug. 17, 2026
- General Catalyst Group Management 2026 Q1 filed May 15, 2026
- General Catalyst Group Management 2025 Q4 filed Feb. 17, 2026
- General Catalyst Group Management 2025 Q3 filed Nov. 14, 2025
- General Catalyst Group Management 2025 Q2 filed Aug. 14, 2025
- General Catalyst Group Management 2025 Q1 filed April 16, 2025
- General Catalyst Group Management 2024 Q4 filed Jan. 23, 2025
- General Catalyst Group Management 2024 Q3 filed Nov. 6, 2024
- General Catalyst Group Management 2024 Q1 filed May 10, 2024
- General Catalyst Group Management 2023 Q4 filed Feb. 9, 2024
- General Catalyst Group Management 2023 Q3 filed Nov. 9, 2023
- General Catalyst Group Management 2023 Q2 filed Aug. 8, 2023
- General Catalyst Group Management 2023 Q1 filed April 14, 2023
- General Catalyst Group Management 2022 Q4 filed Feb. 15, 2023
- General Catalyst Group Management 2022 Q3 filed Nov. 9, 2022
- General Catalyst Group Management 2022 Q2 filed July 29, 2022